Quadria Capital plans ₹1.3k cr invesment in Maxivision Eye hospital
Quadria Capital, Singapore's healthcare focused private equity firm, on Wednesday announced an investment of up to ₹1,300 crore in Maxivision Eye Hospital, one of India's leading private eye care chains. Quadria will make an initial investment of about ₹600 crore for a significant minority stake, and a further investment of up to ₹700 crore for additional stake, representing one of the largest investments in the eye care services space.
The investment will support the Hyderabad-based eye care chain's ability to scale and serve the growing demand for eye care in India, particularly in tier-2 and tier-3 cities that remain underserved by the Indian eye care market. Founded in 1996 by renowned ophthalmologist Kasu Prasad Reddy, Maxivision was subsequently acquired by GSK Velu in 2010.Maxivision operates 42 centres in five states across South and West India, with a leadership position in Andhra Pradesh and Telangana.
The company offers a full suite of eye care services, including cataract surgery, LASIK and ReLEx Smile treatments, treatments for retinal issues and glaucoma, oculoplasty, as well as neonatal and paediatric eye care. «Quadria's expertise, capital, and focus on operational value creation will put us in an even better position to keep scaling, innovating, and delivering for patients seeking affordable and quality eye care,» said GSK Velu, promoter and chairman of Maxivision.
«Quadria's investment into Maxivision underscores our ambition to invest in regional leaders of Asian healthcare, who offer full-service offerings within a single speciality to the wider population,» said Sunil Thakur, partner, and head of South Asia at Quadria Capital. «The market for eye care in India is expected to grow at a rate of over
. Read more on economictimes.indiatimes.com
